NAT2 and lung cancer: With respect to rapid acetylator phenotype, Sorensen et al pointed out the NAT2 rapid acetylator phenotype seemed to be protective against lung cancer in light smokers but not among heavy smokers.34 Nevertheless, several research indicated rapid acetylator phenotype may contribute to increased risk of lung cancer.23,36,37